Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
Manuel Gutiérrez de Ravé, Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“My pleasure to share that I’ve been promoted to Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies.
l’Il generate RWE as a data-driven decision model to advance blood banking in productivity, quality, and safety by supporting post-market surveillance studies with customers worldwide.
Cross-functionally, I’ll continue collaborating with clinicians, industry leaders, academia, and donor associations to improve transfusion medicine and regulatory frameworks — ultimately strengthening healthcare systems.
Additionally, I’ll provide scientific education to internal and external stakeholders. In today’s digital world, flooded with fake news and unverified information, education stands as a vital pillar of society, now more than ever.
Finally, it’s a privilege to learn from exceptional experts and caring individuals. My deepest gratitude goes to my mentors: Marcia Cardoso and Anna Razatos – I feel profoundly lucky that our paths have crossed.”

Stay updated with Hemostasis Today.
-
Jul 16, 2026, 00:20Mettine Bos: Reflecting on a Fantastic ISTH 2026 in Paris with Team Leiden
-
Jul 16, 2026, 00:19Pierre Grès: Proud to Present My PhD Research at ISTH 2026
-
Jul 16, 2026, 00:19Francis Couturaud: Leela Breton Presents Promising PE Research at ISTH 2026
-
Jul 16, 2026, 00:18Alisa Wolberg: An Honor to Present the Gualtiero Palareti Memorial Plenary Lecture at ISTH 2026
-
Jul 16, 2026, 00:17Edward Lee Carter: What ISTH 2026 Tells Us About the Next Era of Thrombosis Care
-
Jul 16, 2026, 00:17Marc Carrier: Celebrating 25 Years of the Adult Thrombosis Fellowship Program at ISTH 2026
-
Jul 16, 2026, 00:16Nikolaos Kotsiou: The Privilege of Presenting Our Clinic’s Newest Findings at My 1st ISTH 2026
-
Jul 16, 2026, 00:14Empowering the Next Generation of Bleeding Disorders Leaders – WFH
-
Jul 16, 2026, 00:13Wolfgang Miesbach: VOYAGER1 Highlights the Potential of Oral Inno8 at ISTH 2026